Main Menu

DEA’s missed opportunity on medical marijuana

DEA’s missed opportunity on medical marijuana

August 12, 2016 | Sanjay Gupta

There is really just one salient question when it comes to today’s decision by the Drug Enforcement Administration to expand the number of growers of research-grade marijuana, while still not changing the scheduling of marijuana: Will this decision make it significantly easier for scientists to study the medical benefits of marijuana?

The answer sadly is: unlikely. And this is a missed opportunity that could further delay potential therapies to countless people.
Up until today, the University of Mississippi has been the only federally approved source of research-grade medical marijuana in the United States. In a bit of seemingly positive news today, the DEA also announced it will now allow other places to apply for permission to do the same. The hope is that marijuana available for scientific study could grow in both amount and diversity.





Comments are Closed